Immuno-Oncology | Specialty

Outcomes With Chemotherapy in BRAF-Mutant NSCLC

December 22nd 2016

Understanding the BRAF-mutated Population in NSCLC

December 22nd 2016

Current Mutation Testing in Lung Cancer

December 22nd 2016

Dr. Dadu on Treatment Approaches in Medullary Thyroid Cancer

December 22nd 2016

Ramona Dadu, MD, assistant professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment approaches in medullary thyroid cancer.

The Future of Glioblastoma

December 21st 2016

Emerging Vaccines in Glioblastoma

December 21st 2016

Glioblastoma: The Potential Role of Immunotherapy

December 21st 2016

Overcoming Challenges in Glioblastoma

December 21st 2016

Glioblastoma: Educating Patients on Tumor-Treating Field Therapy

December 21st 2016

Practical Experience With Optune in Glioblastoma

December 21st 2016

Tumor-Treating Field Therapy in Glioblastoma: Patient Selection

December 21st 2016

New Long-term Data for Tumor-Treating Fields in Glioblastoma

December 21st 2016

Glioblastoma: Impact of Tumor-Treating Field Therapy

December 21st 2016

The Role of Chemoradiotherapy in Glioblastoma

December 21st 2016

Glioblastoma: Guideline Recommendations for Treatment

December 21st 2016

Classification and Prognosis of Glioblastoma

December 21st 2016

Glioblastoma: The Role of Resection

December 21st 2016

Multidisciplinary Care in Glioblastoma

December 21st 2016

What is Glioblastoma?

December 21st 2016

Dr. Pavlick on Immunotherapy Clinical Trials in Basal and Squamous Cell Carcinomas

December 20th 2016

Anna C. Pavlick, DO, medical oncologist, NYU Langone School of Medicine, discusses ongoing clinical trials exploring treatment with immunotherapy in patients with basal cell carcinoma as well as squamous cell carcinoma.